Singapore markets closed

Sesen Bio, Inc. (SESN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.5500-0.0038 (-0.69%)
At close: 04:00PM EST
0.5600 +0.01 (+1.82%)
After hours: 07:54PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 108.48M
Enterprise value -69.06M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)1.78
Price/book (mrq)0.66
Enterprise value/revenue -1.15
Enterprise value/EBITDA 2.66

Trading information

Stock price history

Beta (5Y monthly) 0.95
52-week change 3-39.32%
S&P500 52-week change 3-10.10%
52-week high 31.1100
52-week low 30.3650
50-day moving average 30.5071
200-day moving average 30.6099

Share statistics

Avg vol (3-month) 31.12M
Avg vol (10-day) 31.17M
Shares outstanding 5202.76M
Implied shares outstanding 6N/A
Float 8191.15M
% held by insiders 15.99%
% held by institutions 112.96%
Shares short (14 Nov 2022) 43.09M
Short ratio (14 Nov 2022) 43.77
Short % of float (14 Nov 2022) 41.52%
Short % of shares outstanding (14 Nov 2022) 41.52%
Shares short (prior month 13 Oct 2022) 43.23M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022


Profit margin -5.61%
Operating margin (ttm)-43.29%

Management effectiveness

Return on assets (ttm)-7.46%
Return on equity (ttm)-2.07%

Income statement

Revenue (ttm)60M
Revenue per share (ttm)0.30
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)1.23M
EBITDA -25.95M
Net income avi to common (ttm)-3.37M
Diluted EPS (ttm)0.3300
Quarterly earnings growth (yoy)-71.50%

Balance sheet

Total cash (mrq)177.53M
Total cash per share (mrq)0.88
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)5.54
Book value per share (mrq)0.81

Cash flow statement

Operating cash flow (ttm)9.61M
Levered free cash flow (ttm)23.93M